Session Type
Date Time

Self-testing has shifted the paradigm for HIV testing, the first step in the care continuum. Only 7 years ago, use of HIVST was limited due to lack of evidence of accuracy, acceptability, feasibility, and concerns about safety. Through Unitaid's initial catalytic investment in HIV Self-testing (HIVST) demand and supply interventions through the STAR and Atlas projects, followed by large donor investments including the Global Fund, CIFF, PEPFAR, BMGF, we are now witnessing large scale HIVST use around the world since WHO normative guidance for HIVST was released in 2016. Scale up of HIVST is also driving a movement towards differentiated service delivery and acceleration of prevention access, increasing health system resilience against COVID-19 and decreases cost and complexity of services. HIVST provided a foundation from which other self-testing and self-care approaches can now be more readily realized, including sexually transmitted infections, Hepatitis and COVID-19. In this session we will be reflecting on the levers that have contributed to the HIVST market growth and discussing how the evidence from supply and demand side interventions can be applied to self-care and self-testing approaches in other disease areas and present preliminary results from use cases for Covid-19 and Hepatitis C self-testing.

2 min
Purvi SHAH, UNAIDS and WHO, India
1 min
Karin HATZOLD, Population Services International, South Africa
10 min
The role of self-testing in self-care: Lessons learned from HIV Self-Testing introduction and scale up applied to other disease areas.
Frances COWAN, Liverpool School of Tropical Medicine, United Kingdom
7 min
HIVST Market Growth Supply Side: Unitaid/PSI Market Intervention & PSM benchmarking: Quality product mix at competitive price
Aayush SOLANKI, PSI, South Africa
7 min
HIVST Market Growth Demand Side: Strengthening Self Sustained private sector channel with demand side financing initiative: Uganda, Nigeria & RSA
Abiola ADEPOJU, Jhpiego Nigeria (an affiliate of John Hopkins University), Nigeria
10 min
Use Cases for Covid-19 Self-Testing: Preliminary Results to inform Covid-19 Policy guidance
Euphemia SIBANDA, CeSHHAR, Zimbabwe
10 min
Use cases for Hepatitis C Self-Testing – STAR Research framework for general and key populations
Kimberly GREEN, PATH, Vietnam
10 min
Self-Testing, Empowerment and Self-Care: perspectives from lessons learned in implementing HIV self-testing in West Africa
Joseph LARMARANGE, IRD, France
10 min
Digital Platforms for Self-Testing: Use cases for HIV/Covid-19 and Hepatitis-C
Amber SHEETS, Population Services International, Zimbabwe
20 min
Moderated discussion, including Q & A
Thato CHIDARIKIRE, Dept of Health SA, South Africa
Midnight POONKASETWATTANA, APCOM Foundation, Thailand
Aditia Taslim LIM, International Network of People who Use Drugs (INPUD), Indonesia
Sonjelle SHILTON, FIND, Switzerland
Karin HATZOLD, Population Services International, South Africa
Purvi SHAH, UNAIDS and WHO, India
2 min
Purvi SHAH, UNAIDS and WHO, India
1 min
Karin HATZOLD, Population Services International, South Africa